First Time Loading...

Sera Prognostics Inc
NASDAQ:SERA

Watchlist Manager
Sera Prognostics Inc Logo
Sera Prognostics Inc
NASDAQ:SERA
Watchlist
Price: 10.63 USD 1.92% Market Closed
Updated: May 3, 2024
Section:
 

Wall Street
Price Targets

SERA Price Targets Summary
Sera Prognostics Inc

Wall Street analysts forecast SERA stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SERA is 2.75 USD .

SERA Lowest Forecast
Wall Street Target
Not Available
SERA Average Forecast
Wall Street Target
2.75 USD
74% Downside
SERA Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
2.75 USD
74% Downside
Highest
Price Target
Not Available
Sera Prognostics Inc Competitors:
Price Targets
PRLD
Prelude Therapeutics Inc
48% Upside
TLX
Telix Pharmaceuticals Ltd
5% Upside
302440
SK Bioscience Co Ltd
4% Downside
603087
Gan & Lee Pharmaceuticals
26% Upside
PRLD
Prelude Therapeutics Inc
48% Upside
TLX
Telix Pharmaceuticals Ltd
5% Upside
302440
SK Bioscience Co Ltd
4% Downside
603087
Gan & Lee Pharmaceuticals
26% Upside
A
298380
ABL Bio Inc
42% Upside
DTIL
Precision BioSciences Inc
211% Upside
300896
Imeik Technology Development Co Ltd
64% Upside
KYMR
Kymera Therapeutics Inc
44% Upside

Revenue
Forecast

Revenue Estimate
Sera Prognostics Inc

For the last 3 years the compound annual growth rate for Sera Prognostics Inc's revenue is 117%. The projected CAGR for the next 3 years is 315%.

117%
Past Growth
315%
Estimated Growth
Estimates Accuracy
-27%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Sera Prognostics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Sera Prognostics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-10%
Average Miss
What are analyst estimates?

See Also

Summary
SERA intrinsic value, competitors valuation, and company profile.
DCF Valuation
SERA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SERA stock valuation using valuation multiples.
Wall Street Estimates
SERA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SERA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SERA's stock price target?
Price Target
2.75 USD

According to Wall Street analysts, the average 1-year price target for SERA is 2.75 USD .

What is Sera Prognostics Inc's Revenue forecast?
Projected CAGR
315%

For the last 3 years the compound annual growth rate for Sera Prognostics Inc's revenue is 117%. The projected CAGR for the next 3 years is 315%.

ALPHA SPREAD
Join more than 133,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.